Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pharmagreen Biotech's Enterprise Value is $0.62 Mil.
Pharmagreen Biotech's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.41 Mil. Therefore, Pharmagreen Biotech's EV-to-EBIT ratio for today is -1.54.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Pharmagreen Biotech's Enterprise Value is $0.62 Mil.
Pharmagreen Biotech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.41 Mil. Therefore, Pharmagreen Biotech's EV-to-EBITDA ratio for today is -1.54.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Pharmagreen Biotech's Enterprise Value is $0.62 Mil.
Pharmagreen Biotech's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil. Therefore, Pharmagreen Biotech's EV-to-Revenue ratio for today is 311.00.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Pharmagreen Biotech (OTCPK:PHBI) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Pharmagreen Biotech's current Enterprise Value is $0.62 Mil.
Pharmagreen Biotech's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Pharmagreen Biotech's current Enterprise Value is $0.62 Mil.
Pharmagreen Biotech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.
Pharmagreen Biotech's current Enterprise Value is $0.62 Mil.
Pharmagreen Biotech's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
Pharmagreen Biotech's current Enterprise Value is $0.62 Mil.
Pharmagreen Biotech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14 Mil.
Pharmagreen Biotech's current Enterprise Value is $0.62 Mil.
Pharmagreen Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmagreen Biotech Enterprise Value Related Terms
Pharmagreen Biotech Enterprise Value Historical Data
* Premium members only.
The historical data trend for Pharmagreen Biotech's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHBI vs DVLP, CSTF, BLMS: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmagreen Biotech Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Pharmagreen Biotech's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Pharmagreen Biotech's Enterprise Value for the fiscal year that ended in Sep. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmagreen Biotech (PHBI) has a Enterprise Value of $0.62 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pharmagreen Biotech and its competitors.
Is Pharmagreen Biotech's Enterprise Value too high?
Pharmagreen Biotech's current Enterprise Value is $0.62 Mil.
How does Pharmagreen Biotech's Enterprise Value compare to DVLP and CSTF?
Pharmagreen Biotech's Enterprise Value of $0.62 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pharmagreen Biotech and its competitors. Pharmagreen Biotech's current Enterprise Value is $0.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagreen Biotech stock overvalued right now?
Pharmagreen Biotech (PHBI) has a current Enterprise Value of $0.62 Mil. The current Enterprise Value is $0.62 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current Enterprise Value is $0.62 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHBI has been successfully added to your 